Search for Clinical Trial Results

Sponsored By

Hemophilia B - 26 Studies Found

Status Study
Completed Study Name: Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
Condition: Hemophilia B
Date: 2007-12-21
Interventions: Drug: Recombinant Factor IX Coagulation Benefix IV each 12 hours for 2 a 5 days
Completed Study Name: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B
Condition: Hemophilia B
Date: 2006-08-14
Interventions:
  • Drug: Recombinant Coagulation Factor IX (BeneFIX)

Active, not recruiting Study Name: Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Condition: Hemophilia B
Date: 2015-11-23
Interventions: Genetic: AAVrh10FIX non-replicating recombinant AAVrh10 encoding human FIX (hFIX)
Completed Study Name: Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Condition: Hemophilia B
Date: 2016-11-21
Active, not recruiting Study Name: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B
Condition: Hemophilia B
Date: 2011-01-06
Interventions: Drug: Recombinant factor IX Product, IB1001 On-Demand or Prophylaxis
Completed Study Name: Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B
Condition: Hemophilia B
Date: 2017-03-16
Interventions: Drug: BeneFIX BeneFIX is a recombinant FIX that contains nonacog alfa, reconstituted in solvent and admi
Active, not recruiting Study Name: Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
Condition: Hemophilia B
Date: 2012-08-27
Interventions: Biological: AskBio009 Single dose IV injection Other
Completed Study Name: Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B
Condition: Hemophilia B
Date: 2007-06-07
Interventions: Drug: BeneFIX (coagulation factor IX (recombinant)) BeneFIX will be administered according to physician'
Completed Study Name: Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Condition: Hemophilia B
Date: 2009-09-16
Interventions:
  • Genetic: Gene Transfer Periphe
Completed Study Name: Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Condition: Hemophilia B
Date: 2005-08-30
Interventions: Drug: human coagulation Factor IX Other Name: Nonafact
Next >>>